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CLINICAL JUDGEMENT VS. EVIDENCE-BASED PRACTICE: TWO MODELS 
TO PREDICT POSTOPERATIVE HEMATOCRIT FOLLOWING 
UNCOMPLICATED HYSTERECTOMY 
 
SARAH A. MAYER 
 
ABSTRACT 
Background: Hysterectomies are one of the most frequently performed surgical 
procedures in the United States. There are a wide variety of diagnoses that require a 
patient to obtain this procedure, but the majority of hysterectomies are performed for 
benign indications. Currently, gynecologists do not follow a standardized protocol 
surrounding postoperative laboratory ordering, and healthcare professionals can order a 
wide range of tests as often as they choose. Extraneous laboratory orders are disruptive to 
the patients’ well-being and risk their health following surgery. These orders are costly 
for hospital systems, take up precious time of hospital employees, and influence the 
course of patient treatment only in extremely rare circumstances.  
There are few studies that develop exclusion criteria for patients who may not 
require a laboratory test following surgery. Though systems to predict postoperative 
hematocrit have been created, they are complicated and difficult to use. The few studies 
that were performed are yet to be accepted by the medical community, in part because of 
their limited scope. This study will be the first to incorporate the results of robotic 
surgery in the analysis.  
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Objective: The purpose of this study is to determine concrete parameters to indicate that 
a patient is in need of postoperative laboratory work and at risk for anemia or transfusion. 
We aim to develop two comprehensive models that guide surgical practitioners to 
identify the cases which do not require laboratory data. 
Methods: A total of 1027 gynecologic surgeries were performed at Saint Francis 
Hospital and Medical Center between April 1, 2014 and May 31, 2016. This retrospective 
study extracted data from EPIC EMR according to 42 variables preconceived to be the 
leading indicators of postoperative hematocrit and overall healing. Five healthcare 
professionals were surveyed to identify the variables that influence their postsurgical 
patient assessments and their decisions to order blood testing. This information was 
developed into score sheets with differing levels of stringency. Correlation highlighted 14 
of the initial 42 variables as contributors to postoperative hematocrit and an equation 
model was built. Stepwise linear regression was used for univariate and multivariate 
analyses, from which we created our equation to predict all patients’ postoperative 
hematocrit. 
Results: Out of the 1027 initial cases, a total of 602 cases were identified as 
hysterectomies for benign indications. Survey data gave the highest value to urine output 
and heart rate as key indicators of postoperative anemia. From the survey data, two 
clinical scoring sheets with differing stringency were created to guide practitioner 
laboratory ordering. These sheets gave parameters of heart rate and urine output the 
largest correlative weight in determining postoperative hematocrit. However, based on 
regression analysis, parameters of age (AGE), body mass index (BMI), preoperative 
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platelet count (PPC), estimated blood loss during surgery (IO EBL), preoperative 
hematocrit (PHCT) and postoperative fluid bolus orders (POSTOP FB) proved to be the 
key variables impacting postoperative hematocrit (POSTOP HCT). These items were 
translated into the equation: POSTOP HCT = 22.51 – 0.40*POSTOP FB – 0.01*IO EBL 
+ 0.25 PHCT + 0.09*BMI + 0.06*AGE – 0.01*PPC (R-squared = 0.310).  
Conclusions: This study aims to decrease superfluous laboratory testing, as well as to 
contribute to a larger conversation considering the potential merits of clinical judgement 
in a data-driven healthcare system.  We have created a number of comparable strategies 
in order to reduce the number of unnecessary blood draws: two clinical scoring sheets 
and an equation. The score sheets indicate when to order additional testing. These sheets 
are representative of a range of surgical practitioners’ conventional clinical judgement. 
The equation serves as an evidence-based guide for determining postoperative hematocrit 
following benign gynecologic surgery. These predictive mechanisms will be validated 
and a superior method determined as our research continues with prospective application. 
We eventually expect to use the most accurate mechanism to reduce postoperative blood 
testing following all surgeries.  
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INTRODUCTION 
Hysterectomy Is One of the Most Frequently Performed Procedures in the US 
Each year, over 600,000 women in the United States undergo a hysterectomy. 
Hysterectomy is the eighth most common surgery overall, and the second most common 
surgery for women, following only cesarean section. Over a third of all women have 
experienced the procedure (Fingar et. al., 2014). There are records of hysterectomies 
being performed as long ago as the early 1800s, and rates of mortality and morbidity have 
decreased significantly in the past 100 years (Sutton, 1997). Hysterectomies show 
consistent need across many demographics, utilized by all racial groups and within every 
socioeconomic level (Swenson et. al, 2015). There are a variety of diagnoses leading 
clinicians to recommend hysterectomy, ranging from ovarian cancer to endometrial 
hyperplasia to uterine prolapse. Women also regularly elect to have this surgery as a 
solution to painful endometriosis, abnormal uterine bleeding, or to lower their cancer 
risks when faced with a genetic mutation (Whiteman et. al., 2008). In 2003, over 90% of 
hysterectomies performed were for benign indications (Wu, Wechter et. al., 2007). In the 
vast majority of cases, the procedure is performed to stop the pelvic pain and bleeding 
associated with uterine fibroids, which are noncancerous, hormone-sensitive growths of 
the uterus that can become numerous and very large (Swenson et. al., 2015). Figure 1 
illustrates the incidence of these conditions across a range of surgical techniques. 
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Figure 1. Diagnoses and Indications for Benign Hysterectomy Organized by Route. For 
all benign hysterectomies, the most common indications were leiomyomata, or fibroids 
(37%), menstrual disorders (19%), prolapse (13%), and endometriosis (12%). This figure 
was obtained from Wu, Wechter et. al., 2007. 
 
 
Types of Hysterectomy Vary and Have Differing Effects on Patient Hematocrit 
The form of hysterectomy may significantly impact patient recovery time and 
follow-up experiences (Meikle et. al., 1997). There are two different types of 
hysterectomy relevant to this study, each with its own risk of blood loss and recovery 
schedule. A supracervical hysterectomy involves only the upper part of the uterus, with 
the patient maintaining the cervix, the fallopian tubes, and the ovaries in place. Some 
studies have suggested that this option is underutilized, as surgeons routinely choose to 
remove the cervix as a precaution against future illness, despite a lack of evidence to 
indicate the necessity of this step (Lethaby et. al., 2012). A total hysterectomy is limited 
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to removal of the uterus and cervix, leaving the ovaries and fallopian tubes intact. 
Applicable to so many of the abnormal bleeding disorders and gynecologic dysfunctions 
that most commonly warrant hysterectomy, this type of procedure is employed with the 
greatest frequency (Wu, Wechter et. al., 2007). Though yet to be definitively determined, 
there is reason to believe that a total hysterectomy, removing the larger amount of tissue, 
would put patients at a higher risk for low postoperative hematocrit than a supracervical 
hysterectomy, which removes the less amount of tissue. Future studies are needed to 
specifically determine the way these surgeries impact patient blood counts. Often, 
regardless of the surgery type, blood work is performed to understand exactly how an 
individual patient’s hematocrit was influenced and to ensure a patient will be able to 
recover appropriately.  
 
Routes of Hysterectomy Vary and Have Differing Effects on Patient Hematocrit 
There are several routes of hysterectomy available, each with a unique risk to 
hematocrit.  Traditionally, the surgery is performed vaginally, abdominally (also called 
via laparotomy), and laparoscopically. Vaginal hysterectomies are performed primarily 
through the vaginal canal. This option is traditionally the first choice for patients, as it 
boasts the shortest healing time and is associated with the fewest complications (Johnson 
et. al., 2006). The effect of vaginal hysterectomy on postoperative hematocrit is 
controversial. Whereas some studies show the procedure should not be recommended to 
patients with low hematocrits because it causes greater intraoperative blood loss, others 
have indicated vaginal hysterectomy offers the lowest incidence of transfusion (Swenson 
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et. al., 2016; Boggess et. al., 2008). In a laparotomy, tissue is removed through an 
incision in the lower abdomen, putting the patient at greater risk for wound infection, 
bleeding, and nerve tissue damage. This procedure requires the longest hospital stay and 
has the highest rate of complications (Balakrishnan and Dibyajyoti, 2016). Developed in 
the late 1980s, laparoscopic techniques are still relatively new to the surgical world, and 
clinicians are always making efforts to decrease patient pain, discomfort, complications, 
and hospital stay (Fuchs, 2002; Jones and Jones, 2001). Laparoscopic hysterectomy is 
performed using three or more small incisions in the abdomen. This minimally invasive 
route has a similar healing time to vaginal hysterectomy, but the operative time is 
significantly longer, increasing certain intraoperative risks (Boggess et. al., 2008). 
Because of the conflict surrounding the effects of vaginal hysterectomy on patient 
hematocrit and the significant blood loss inherent with laparotomy, laparoscopic 
hysterectomy is currently the recommended route for a patient struggling with a low 
hematocrit prior to surgery. Practitioners often utilize blood work to concretely measure 
the impact to a patient’s hematocrit following one of these invasive surgeries. 
 
Robotic Hysterectomy Studies Are Vague Regarding Effects on Patient Hematocrit 
Many of the studies assessing the route of hysterectomy and the related change in 
patient hematocrit have failed to include data on robotic surgery. Robotic techniques have 
increasingly replaced laparotomy and conventional laparoscopy. The earliest 
opportunities for robotic-assisted surgery were in the late 1980s, and the platform 
obtained approval to perform gynecologic procedures in 2005 (Liu et. al., 2012). These 
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systems increase surgeon dexterity and coordination and improve visualization 
(Lanfranco et. al., 2004). Additionally, robotic surgeries continue to aim at expanding the 
healing benefits beyond laparoscopic practices, with an observed decrease in 
complication risk, regardless of complexity (Luciano et. al., 2016). Due to the limitations 
of robotic systems, namely the cost and size, there have been very few studies that 
conclusively evaluate the use of robotic surgery in gynecologic settings. Despite this 
issue, the use of robotic platforms continues to grow explosively, with an increase of use 
in hysterectomy for benign indications from 0.5% in 2007 to 9.5% in 2010, making these 
analyses more vital than ever (Wright et. al., 2013). There is nothing currently published 
that offers a sense of the influence of robotic systems on specific healing-related 
parameters, namely, postoperative hematocrit. 
 
Racial Disparities in Hysterectomy Impact Patient Hematocrit 
Though women of all backgrounds benefit from hysterectomies, there are some 
important racial trends in gynecologic surgery. Black women have been shown to be 
more likely to undergo hysterectomy than white women. This tendency persists after 
controlling for body mass index (BMI), incidence of polycystic ovary syndrome (PCOS), 
tubal ligation, depressive symptoms, education, access to medical care, geographic site, 
fibroid diagnosis, and age at menarche (Bower et. al., 2009). These studies often fail to 
take Hispanic/Latina and Asian women into account, typically because their racial 
categories are frequently unspecified in electronic medical records and surveys. However, 
there is some evidence that patients of both groups are less likely than white women to 
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obtain the procedure (Kersharvarz and Marchbanks, 2002; Brett and Higgings, 2003; 
Powell et. al., 2005).  
There is variation in the hysterectomy route and outcomes among racial groups. 
One study found that black, Hispanic/Latina, and Asian women—when controlling for 
age, income, region, insurance, hospital characteristics, and diagnosis—are more likely to 
obtain a laparotomy procedure than white women (Kuppermann et. al., 2010). 
Unsurprisingly, considering the route of surgery, black and Asian women are also more 
likely to have a surgical complication, regardless of age, insurance, indication, co-
morbidities, or other surgeries (Jacoby et. al., 2010). Because of these variations, it is 
imperative to have representative patient study populations when considering 
postoperative hematocrit.  Additionally, the results of these studies may be influenced by 
psychosocial and socioeconomic factors such as access to surgical care or alternative 
therapies as well as cultural or personal surgical preferences. As a result, these patterns 
must continue to be evaluated.  
 
Postoperative Bloodwork Risks Patient Healing and Comfort at a Critical Period  
Though hysterectomy is considered one of the safest procedures, as with any 
surgery, there are serious risks. These types of issues include wound infection, heavy 
bleeding, thrombosis and embolism, pulmonary or cardiac problems resulting from 
anesthesia, and even death (Makary and Daniel, 2016). Moreover, there are a number of 
risks specific to hysterectomy, such as ovarian failure or premature menopause, sexual 
and pelvic pain, injury to the urinary tract and urinary incontinence, vaginal prolapse, 
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adhesion formation, and bowel obstruction (Dessources et. al., 2015). Some women are at 
a greater risk of complications than others, particularly those with an underlying medical 
condition. Table 1 summarizes the risks of complications specific to each major type of 
hysterectomy. 
Regardless of the type or extent of the surgery, it is vital that patients are allowed 
time to rest and heal in the days and weeks following (Kjølhede et. al., 2012). Providers 
must prioritize this restorative period in order to ensure that their patients’ wounds close 
and inflammation subsides appropriately. The process of obtaining the blood is painful to 
and inconvenient for patients, taking time away from rest and healing. Hysterectomy 
already risks so many bleeding-associated complications, and frequent blood draws 
further impact a patient’s hematocrit levels. The disruption to patient recovery associated 
with frequent blood testing makes it all the more important to perform thorough analysis 
of every convention around postoperative bloodwork. Patients who are not allowed this 
dedicated interval to heal are at risk for an increased rate of complications (Catanzarite et. 
al., 2015). It is possible that the certain postoperative care procedures negatively affect 
patients and their healing in the critical first few days after surgery. Beyond further 
delaying the restorative process, any surgical complications also require subsequent 
medical interventions which prolong hospitalizations, keep patients away from their 
families and work, and drive up their healthcare costs.  
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Table 1. Complication Rates Associated with Abdominal, Laparoscopic, and Vaginal 
Hysterectomy. Abdominal hysterectomy is associated with the highest risk of 
complication, and vaginal hysterectomy is associated with the lowest rates. Numbers and 
percentages are included. This study, like many others, does not have data on the use of 
robotic techniques (Boggess et. al., 2008). 
 Abdominal 
(n = 138) 
Laparoscopic 
(n = 81) 
Vaginal 
(n = 103) p-Value 
Total 
postoperative 
complications 
40 (28.9%) 8 (9.9%) 5 (4.9%)  
Overall 
complication 
rate 
41 (29.7%) 11 (13.6%) 6 (5.8%) <0.0001  
Transfusion 2 (1.5%) 2 (2.5%) 1 (1.0%) 0.51 
 
 
Blood Draws Are Painful, Costly and Inconvenient for Patients and Hospital Systems 
There are a number of practical issues associated with the request for excessive 
blood draws following surgery. The blood draws themselves demand the time of hospital 
staff to obtain and review, draining hospital resources (Abbett et. al., 2015). These blood 
draws have a range of costs—typically about $50 a test—but insurance companies only 
reimburse the hospital approximately $9.80 a test. With these numbers in mind, studies 
estimate that the healthcare system could save almost $3 million dollars in costs if blood 
work was no longer ordered following laparoscopic hysterectomy alone (Chamsy et. al., 
2014). With so few patients truly requiring the transfusion that follows an exceptionally 
low postoperative hematocrit and with the results of the testing so rarely influencing the 
course of treatment, it seems more important than ever to find a non-invasive, 
inexpensive way to avoid this laboratory work. 
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The Standard Regarding Patient Bloodwork Following Hysterectomy Is Uncertain 
Standardized protocols for patient care and management are put in place to 
prevent provider error and patient harm. When assigned appropriately, these practices are 
effective tools for improving healthcare quality. In the constantly changing healthcare 
landscape, however, protocols must be frequently reconsidered and adjusted in order to 
ensure the most safe and successful patient care. Currently, it is typical for a practitioner 
to order blood draws immediately following surgery as well as additional laboratory 
testing in the days after the procedure, but a concerned medical professional may order 
blood counts several times in a single day. Unsurprisingly, patients with symptoms 
suggesting postoperative anemia, such as dizziness, tachycardia, hypotension and low 
urine output, are increasingly likely to experience repeat testing (Chamsy et. al., 2014). 
Though all symptomatic patients have at least one additional hematocrit ordered, 9.6% of 
asymptomatic patients also have a second postoperative hemoglobin ordered, with 1.6% 
of health practitioners ordering a third. There is very little information in the literature to 
guide this standard of follow-up care (Swenson et. al., 2015).  
The primary purpose of postoperative blood testing is to indicate transfusion, 
which is very unlikely following gynecologic surgery. Studies find the risk of transfusion 
with any gynecologic procedure to be 1.9%, whereas incidence of postoperative 
transfusion associated with hysterectomy is even lower at 1.2% (Kohli et. al., 2000). 
Postoperative blood draws very often do not lead to any new medical conclusions. 
Studies indicate that the results of these tests, however extreme, rarely independently 
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impact the course of care (Murphy et. al., 2013). Studies have cited the additional 
insurance and confidence that doctors feel following exhaustive testing to be a strong 
motivator for writing these orders (Sonnenberg and Boardman, 2013). These preliminary 
results imply that a portion of blood testing performed might have been ordered because 
of habit or hospital convention rather than patient need or other concern for patient well-
being. Without a concrete standard, the use of arbitrary decision-making can lead to 
indiscriminate variation in patient care as a result of personal bias or lack of information, 
can endanger a patient’s or provider’s life with the risk of infection, and can leave a 
patient open to additional human error (WHO, 2010).  
 
Few Studies Evaluate the Use of Postoperative Bloodwork Following Hysterectomy 
As more and more reports have revealed the substandard reality of healthcare 
today, researchers and medical professionals have continued to work toward evidence-
based performance improvement in order to provide the highest level of care for patients 
(Kohn et. al., 2000). Practitioners are under immense pressure to save hospital costs 
without sacrificing a positive patient experience or outcome (Makary and Daniel, 2016). 
To date, there are very few quality assurance studies that focus on hysterectomy and none 
that consider postoperative hematocrit under surgical conditions including robotic 
surgery. This is of particular concern because, as mentioned previously, the method and 
the route of hysterectomy have a large influence over each patient’s outcome, and the use 
of robotic techniques is increasingly widespread. Without data to guide patient care, 
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healthcare professionals are left to refer to their own judgement and convention, which 
chances misinformation and inappropriate care (Abbett et. al., 2015).  
 
Building on a Previous Predictive Model of Postoperative Hematocrit 
One study in particular has led the charge in encouraging increasingly selective 
postoperative hematocrit testing. Swenson et. al. (2015) from the Michigan Surgery 
Quality Collaborative published a study with a model predicting postoperative hematocrit 
levels following benign hysterectomy. Use of this model would allow surgical 
practitioners to anticipate their patients’ blood results within a percentage point and 
would require no invasive procedure. This research revealed little to no difference in 
postoperative hematocrit following laparoscopic and abdominal hysterectomy. 
Preoperative weight, preoperative hematocrit and route of hysterectomy were identified 
as key factors that led to an increased patient postoperative hematocrit. Researchers also 
emphasized higher estimated blood loss, higher intraoperative crystalloid volume and 
higher preoperative platelet count as significant indicators of a low postoperative 
hematocrit. These results and the related model have greatly adjusted the standard 
practice at the study institution.  
This project, however, was not without its limitations. The demographics of the 
patient population in the study differed from the national averages, with a limited number 
of minority patients. Robotic methodology was also not considered in the study grouping, 
which may have influenced the findings and indicates an incomplete data set. Lastly, the 
study focused on 19 key variables, but it is possible that other parameters may have a 
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more specific role in determining postoperative hematocrit. With the success that this 
promising research has attained, it is important to expand the data set and continue this 
progress. 
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SPECIFIC AIMS 
This retrospective chart review examines the ordering of unnecessary 
postoperative hematocrit studies in asymptomatic patients, specifically those requested in 
the immediate postoperative period or on the first postoperative day following 
hysterectomy for benign indications. The specific aims of the review are to:  
• Promote clinical quality, evidence-based practice and cost efficiency by reducing 
superfluous postoperative laboratory studies following hysterectomy for benign 
indications. 
• Describe and analyze the baseline practices regarding how often hematocrit 
studies are ordered postoperatively for patients who have undergone hysterectomy 
for benign indications. 
• Develop and compare two standardized pathways for postoperative management 
following hysterectomy for benign indications—one representative of 
conventional ordering and the other guided by evidence-based practice. 
• Draw conclusions to allow for future study expansion to larger patient populations 
and significantly impact the quality and cost effectiveness of postoperative patient 
management following gynecologic and other significant surgical procedures. 
• Contribute uniquely to the gynecologic and broader surgery literature by 
conducting research in an area of limited discovery. 
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METHODS 
Study Population and Eligibility 
This retrospective study analyzed data from Epic EHR (electronic health records) 
for all hysterectomies performed at Saint Francis Hospital and Medical Center in 
Hartford, CT, from April 1, 2014, to May 31, 2016. It was approved by Saint Francis 
Hospital and Medical Center Institutional Review Board and was designed to identify the 
current laboratory practices of clinicians following benign hysterectomy as well as to 
develop a standardized pathway for future care. Funding for this project was obtained 
through the Best Care grant program at Saint Francis, which provides resources for 
studies that aim to advance the clinical quality, patient safety, patient experiences and 
continuous improvement standards at Saint Francis Hospital and Medical Center.  
Data were reviewed from all women who underwent a hysterectomy during the 
study period. Data extraction was performed by all members of the investigative team. 
Exclusion criteria included a diagnosis of cancer, pregnancy, or a surgical diagnosis 
involving other concomitant surgeries. There were a range of gynecologic indications for 
the study; no limits were placed on the method or route of surgery, the operative time, or 
the patients’ preoperative hematocrits. A total of 42 parameters were extracted from 
electronic records for analysis. These variables included operative time, procedure type, 
procedure method, preoperative diagnosis, hematocrit prior to surgery, estimated blood 
loss during surgery, anticoagulant use, intraoperative urine output, preoperative and 
postoperative heart rates, preoperative and postoperative blood pressures, postoperative 
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fluid bolus and iron sulfate orders, discharge diagnosis, preoperative platelet count and 
length of patient hospital stay. 
Clinical characteristics analyzed included age, race and ethnicity, body mass 
index and insurance status. Race was determined as patients reported their identification 
as Asian, black, white, or other. Ethnicity was also self-reported as patients were asked to 
identify if they were Hispanic/Latina.  
 
Clinical Score Sheets 
In addition to the mathematical model for predicting postoperative hematocrit, 
five healthcare professionals were surveyed to develop an approach reflective of 
traditional practitioner ordering behavior based on clinical judgement and intuition. 
These physicians and physician assistants, all employees of Saint Francis Hospital and 
Medical Center, offered their own personal parameters and warning signs when assessing 
a patient’s status following surgery. Of the 42 parameters included in the data set, each 
healthcare professional gave input into the criteria that are most valuable in making the 
decision to order postoperative laboratory work. These variables were valued—with 
additional points given to the most significant variables—and developed into a scoring 
system. The parameters utilized, as well as the weight given to each, were representative 
of traditional clinical considerations and practitioner conventions following 
uncomplicated hysterectomy. The averages of the responses and the values offered were 
condensed into formal scoring sets.  
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Statistical Analysis 
Our retrospective study developed and analyzed a postoperative hematocrit 
prediction model.  Modeling and statistical analyses were done using SAS version 9.4 
(SAS Institute, Cary, NC, USA). Patient demographics along with the 42 preoperative, 
intraoperative and postoperative characteristics were collected. Correlations between the 
lowest postoperative hematocrit values and other independent variables were examined. 
 
Predictive Model 
Based on the correlations and clinical expertise, the following 14 variables were 
considered for the multivariate model: age, race, BMI, procedure type and number of 
procedures, lowest preoperative hematocrit level, preoperative systolic and diastolic 
blood pressure, operative time, blood loss, minimum platelet count, length of stay, 
number of postoperative fluid boluses ordered and 24-hour urethral catheter output.  The 
model was derived by entering the 14 preselected variables into a stepwise linear 
regression. The final model retained variables with a p-value <0.05 in a type III test of 
fixed effects. The fixed effects were retained only if their addition to the model 
significantly improved model fit.  Regression coefficients for the final 6 variables were 
used to create the equation to predict postoperative hematocrit. This model is intended to 
be integrated with and applied to EMR (electronic medical records) software directly in 
order to predict a patient’s postoperative hematocrit and to assist in guiding the ordering 
behavior of healthcare professionals. 
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RESULTS 
 
Overall Data and Study Population 
There were 1027 hysterectomies performed at Saint Francis Hospital and Medical 
Center during the study period. Table 2 lists the specific details of these surgical cases.  
Of the 1027 initial cases, 602 were uncomplicated and met the criteria for inclusion in the 
study. Patients with all diagnoses of abnormal bleeding, including fibroid uterus, 
comprised 68% of the eligible group. Less than 2% of the patients in the eligible cohort 
received a transfusion. Of the 425 ineligible cases, 90% involved patients with a surgical 
diagnosis of cancer or a complicated, multi-procedural surgical plan. This group was 
almost five times more likely to obtain a transfusion than the uncomplicated cohort. 
The study population was diverse. Table 3 describes the demographics and 
characteristics of the eligible surgical cases. A total of 58% of the patients identified as 
white, 24% identified as black and 16% identified as Hispanic/Latina The average patient 
was approximately age 50 and had a BMI of about 31. Overwhelmingly, the patients in 
this group were postmenopausal and had BMIs above the normal range.  
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Table 2. Description of the Overall Data. The breakdown of the eligible and non-eligible 
cases will be taken into consideration with further study. The percentages detailed in the 
eligible and ineligible subgroups were taken from the larger total number of cases as well 
as from the smaller eligible or ineligible number. Transfusion subgroups were not 
excluded from the other two groups. 
 Cases (n) Percentage (Total) Percentage (Subgroup) 
Total number of cases 1027 100%  
Eligible cases 602 59%  
1. Bleeding-related 
diagnosis 
409 40% 68% 
2. Non-bleeding 
indications  
193 19% 32% 
3. Eligible case 
transfusions 
10 1% 2% 
Ineligible cases 425 41%  
1. Pregnancy-related 
surgery cases 
42 4% 10% 
2. Cancer-related or 
complicated 
surgery cases 
383 37% 90% 
3. Ineligible case 
transfusions 
46 4% 11% 
 
 
Table 3. Characteristics of the Eligible Population. The patient population data from the 
602 eligible surgical cases were listed here. Average and range information has been 
included, where applicable. Racial criteria is consistent with charting information. 
Postmenopausal patients were determined to be age >45. BMI = body mass index = 
[weight (kg)] / [height (cm)]2; PNA = preferred not to answer.  
 Patients (n) Percentage Average Range 
Asian 13 2%   
Black 144 24%   
Hispanic/Latina 95 16%   
White 345 58%   
Unknown/PNA 5 1%   
Age 602 100% 49.8 22-84 
Premenopausal 229 38%   
Postmenopausal 373 62%   
BMI 602 100% 30.8 16-72 
Healthy BMI 138 23%  18-25 
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Surgical Variables and Hematocrit Data 
 This study analyzed several different types and routes of hysterectomy as 
potential influencers of postoperative hematocrit. Table 4 summarizes these surgical 
variables. At 80% of the cases, the vast majority of patients received a total 
hysterectomy. Patients were 3 times more likely to have their surgery performed 
robotically than laparoscopically. There is a high percentage of cases—15%—in which 
the route of hysterectomy was not clearly identified in the electronic chart.  
 Data were also included on the current postoperative laboratory ordering practices 
of the surgical clinicians at Saint Francis Hospital and Medical Center. Table 5 displays 
the variation in the frequency of requests, with the number of orders per case ranging 
from 0-14. On average, practitioners ordered more than one (1.42) blood draw for each 
patient. Most notable, almost 20% of healthcare professionals wrote two or more requests 
for blood work following uncomplicated hysterectomy. These practices may be related to 
the preoperative hematocrit numbers, also displayed in Table 5, where 40% of patients 
had values below normal. Sixteen percent of the data was not clear or not included and 
has been listed as incomplete.  
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Table 4. Description of Surgical Variables in Eligible Population. Table details the 
breakdown of surgical type and route in the eligible study group of 602 patients. Patients 
in this group overwhelmingly received total hysterectomies and utilized robotic 
techniques. The data were presented as indicated in chart reports. 
 Number Cases Percentage 
Hysterectomy Type   
Total 479 80% 
Vaginal 107 18% 
Supracervical 16 3% 
Hysterectomy Route   
Laparoscopic 92 15% 
Laparotomy 135 22% 
Robotic 287 48% 
Unspecified 88 15% 
 
 
Table 5. Description of Eligible Hematocrit Data. Preoperative hematocrit was often 
determined prior to surgery at the patient’s primary care office. A hematocrit value below 
38% is considered below normal (Wu, Schifftner et. al., 2007). On average, the number 
of postoperative hematocrits ordered per patient was >1. Data included on the percentage 
of occasions that hematocrit value is ordered simply once (1x) compared with two or 
more times (2+). Incomplete data was typically a result of human or computer error 
leading to inconclusive results. The data is presented as indicated in chart reports. PH = 
postoperative hematocrit. 
 Number Cases Percentage Average Range 
Preop hematocrit   38 14.1-56.0 
Preop hematocrit 
below 38 
238 40% 34.2  
Average PH labs 
ordered per case 
  1.42 0-14 
PH labs ordered 1x 396 66%   
PH labs ordered 2+ 112 19%   
PH labs data 
incomplete 
95 16%   
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Clinical Score Sheets and Equation Guide for Postoperative Laboratory Ordering 
The study resulted in two scoring systems that have the potential to assist 
clinicians in deciding to order postoperative blood tests. These systems are intended to be 
used as tally guides for clinicians who have patients at risk of requiring postoperative 
bloodwork. Table 6 describes the first of the two scoring sheets. A patient who meets 
each condition mentioned on the sheet will accumulate points up to a 14-point total. A 
score of 5 or higher will indicate that the practitioners should order a laboratory test.  On 
this scoring system, a heart rate of greater than 100 BPM (beats per minute) and a urine 
output of less than 20 cc/hr carry the highest value in terms of predicting a low 
postoperative hematocrit. Parameters common to both systems are the age limitation (a 
patient greater than 75 years of age is most vulnerable to a symptomatic low 
postoperative hematocrit), the changes to blood pressure, the use of transfusion within the 
current admission, the estimated blood loss and more than 4 postoperative fluid bolus 
orders. This sheet also contains as variables a preoperative hematocrit of less than 28, use 
of laparotomy in surgery, surgical time of greater than four hours and a patient currently 
taking anticoagulants.  
Table 7 displays the parameters indicated in the second, less conservative score 
system. A patient who meets each condition mentioned on this table will accumulate the 
related number of points out of a possible total of 11 and a score of 3 or higher will 
indicate that the healthcare professional should order a laboratory test. With this scoring 
system, a heart rate of greater than 105 BPM and a urine output of less than 20 cc/hr are 
the most significant predictors of a postoperative anemia. An estimated blood loss of 
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greater than 800 cc is an indicator compared with greater than 500 cc in the first scoring 
system, as well as a preoperative hematocrit of less than 25, compared with less than 28 
in the first system. Indications regarding the use of laparotomy, surgical time and 
prescribed anticoagulants were removed. 
Of the 602 eligible cases, 338 had data that were complete for use in identifying 
key parameters and developing an equation for future validation. These data are included 
in Table 8. Intraoperative estimated blood loss, preoperative platelet count and 
postoperative fluid bolus orders indicated a small negative correlation with postoperative 
hematocrit. Preoperative hematocrit, patient BMI and patient age all resulted in a positive 
correlation with postoperative hematocrit. The highest correlative values were 
preoperative hematocrit, with a regression coefficient of 0.250 (p < 0.0001) and 
postoperative fluid bolus orders, with a regression coefficient of -0.399 (p = 0.0001). Of 
the original 14 variables, 6 were found to be statistically significant. These data were 
adapted into an equation for clinician use, shown in Figure 2.  
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Table 6. Clinical Scoring Sheet 1. This data was obtained via survey of healthcare 
professionals. The indicators and their weights were based on healthcare professional 
personal preference and clinical judgement. The table indicates that a patient with a score 
of 5 or higher should have bloodwork performed. BPM = beats per minute. 
 
Blood Draw Score Sheet: Trial 1  
Points: Out Of: Parameter: Parameter Detail: 
  1 Age >75 years old 
 1 Diastolic Pressure Drop >20 pts from 
preoperative level 
 1 Systolic Pressure Drop >40 pts from 
preoperative level 
 1 Preoperative 
Hematocrit 
<28 
 2 Heart Rate <100 BPM 
 1 Previous Transfusions Within current 
admission 
 1 Fluid Boluses >4 
 1 Laparotomy  
 1 Estimated Blood Loss >500 cc 
 2 Urine Output <20 cc/hr 
 1 Surgical Time >4 hr 
 1 Anticoagulants Currently taking 
 14 Total (5 or higher, obtain blood work) 
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Table 7. Clinical Scoring Sheet 2. This data was obtained via survey of healthcare 
professionals. The indicators and their weights were based on healthcare professional 
personal preference and clinical judgement. The table indicates that a patient with a score 
of 3 or higher should have bloodwork performed. BPM = beats per minute. 
 
Blood Draw Score Sheet: Trial 2  
Points: Out Of: Parameter: Parameter Detail: 
  1 Age >75 years old 
 1 Diastolic Pressure Drop >20 pts from 
preoperative level 
 1 Systolic Pressure Drop >40 pts from 
preoperative level 
 1 Preoperative 
Hematocrit 
<25 
 2 Heart Rate >105 BPM 
 1 Previous Transfusions Within current 
admission 
 1 Fluid Boluses >4 
 1 Estimated Blood Loss >800 cc 
 2 Urine Output <20 cc/hr 
 11 Total (3 or higher, obtain blood work) 
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Table 8. Data-Based Model for Predicting Postoperative Hematocrit. Variables were 
indicated by SAS version 9.4. Fourteen preselected variables were entered into stepwise 
linear regression in order to develop the model. Of the 602 eligible patients, 338 had 
sufficient data for model creation. Only 6 of the 14 variables were found to be 
statistically significant. POSTOP HCT = postoperative hematocrit, POSTOP FB = 
postoperative fluid bolus orders, PHCT = preoperative hematocrit, IO EBL= 
intraoperative estimated blood loss, BMI = body mass index, AGE = patient age in years 
and PPC = preoperative platelet count. DF = degrees of freedom. 
 
  R-squared: 0.310 
Key Variables DF Parameter 
Estimate 
Standard 
Error 
t-Value p-Value 
IO EBL 1 -0.009 0.001 -8.45 <0.0001 
PHCT 1 0.250 0.049 5.13 <0.0001 
BMI 1 0.087 0.029 3.06 0.0024 
AGE 1 0.057 0.021 2.74 0.0065 
PPC 1 -0.010 0.004 -2.92 0.0038 
POSTOP FB 1 -0.399 0.122 -3.25 0.0001 
 
 
 
 
Figure 2. Predictive Equation. Variables were indicated by SAS version 9.4. Fourteen 
preselected variables were entered into stepwise linear regression in order to develop the 
model. Regression coefficients for the final 6 variables were used to create the equation. 
POSTOP HCT = postoperative hematocrit, POSTOP FB = postoperative fluid bolus 
orders, PHCT = preoperative hematocrit, IO EBL= intraoperative estimated blood loss, 
BMI = body mass index, AGE = patient age in years and PPC = preoperative platelet 
count. 
 
 
 
POSTOP HCT = 
22.51 - 0.40*POSTOP FB - 0.01*IO EBL + 0.25 PHCT + 0.09*BMI + 
0.06*AGE - 0.01*PPC 
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DISCUSSION 
This project contributes uniquely to the literature around gynecologic and broader 
surgery by conducting research in an area of limited discovery, specifically the necessity 
and frequency of postoperative hematocrit testing. Our retrospective chart review 
considered all eligible 602 uncomplicated hysterectomy cases from April 1, 2014, to May 
31, 2016, with the goal of gathering data to safely and effectively deter the ordering of 
unnecessary postoperative hematocrit studies in asymptomatic patients. Extraneous 
laboratory orders are disruptive to the patients’ well-being and risk their health following 
surgery. In addition, these orders are costly for hospital systems, take up precious time of 
hospital employees and influence the course of patient treatment only in extremely rare 
circumstances. Once expanded to other patient populations, this study has the potential to 
significantly impact the quality and cost effectiveness of postoperative patient 
management following gynecologic and other major surgical procedures. 
 The initial steps of the study involved a complete analysis of the current ordering 
practices utilized by practitioners managing the eligible patient cases. This primary 
exploration involved the creation of two models, each with the capacity to directly guide 
postoperative laboratory ordering. In the first model, two scoring systems were created 
with input from relevant healthcare professionals, reflecting their clinical judgement and 
the overall state of current practice. The second model was a comparable evidence-based 
equation that was developed using the electronic health record data. A discussion of the 
merits and inadequacies of each predictive model is essential prior to determining a 
superior technique through further data validation. 
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Analysis of the Study Population  
The racial and ethnic patient determination is diverse. The patient demographics 
are consistent with that of a metropolitan population and closely reflect the national 
averages (Census, 2016). The population ages are consistent with the expected averages 
for a patient group approaching hysterectomy. These consistencies indicate that the data 
in this study will readily apply to a wider population. 
BMI values of the patient study population are high. Reasons for this large BMI 
group could be lack of resources or access to healthy food in this urban area. Lack of 
patient education about healthy eating and exercise could also be a reason. Additionally, 
patients may not have the income to afford fresh produce and other lower calorie foods. 
With obesity on the rise, it is not unexpected to see increasingly overweight patient 
populations in research studies. 
 
Analysis of Postoperative Hematocrit and Ordering Behavior  
With an average of 1.42 blood draws for each patient, the majority of patients will 
have their hematocrit checked more than once following a single surgery. Considering 
that less than 2% of patients in our eligible data set required a transfusion, we can see that 
there is very often laboratory effort, staff time and patient pain and inconvenience 
expended without benefit. This unnecessary ordering is certainly an issue at Saint Francis 
Hospital and Medical Center, as it likely is in many hospitals nationally. More research 
must be done to determine exactly the source of this practice. Frequent laboratory 
ordering may simply be a behavior that has not been examined prior to these studies in 
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recent years. Healthcare leaders may not recognize the costs and therefore assume that 
additional testing will ensure superior care by contributing extra assurance for the patient 
and provider alike. Another possibility is that the administration encourages this behavior 
to prevent medical malpractice suits. Improved understanding of the nuances that lead to 
excessive laboratory ordering will only allow healthcare stakeholders to more effectively 
overcome the problem. 
 
Analysis of the Clinical Scoring System 
The clinical scoring system allows healthcare professionals to rate a patient’s 
health status following a postsurgical assessment and demonstrates the need for 
laboratory work. These scores are intended to reflect and reinforce the conventional 
wisdom a healthcare professional uses in deciding to order blood work. Because the 
scoring system is anticipated to represent conventional clinical medicine, which takes 
into account both past experience and medical judgement, clinicians can quickly and 
easily apply this reference to patient data in real time.   
Two scoring systems were created, instead of simply one, to account for the 
natural variation in healthcare professional clinical decision-making in regard to 
postoperative laboratory ordering. Some clinicians are more conservative than others, as 
is one of the two scoring guides. However, both scoring systems have relatively low 
values to indicate when blood work should be performed. In each sheet, a patient has to 
meet only approximately one-third of the criteria in order to warrant an order. It is 
possible that the low thresholds of the systems will lead to the same surplus of requests 
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for blood work that is current practice. Our validation step will indicate which of these 
scoring sheets will be able to guide a comfortable clinical balance. 
 
Equation Analysis 
We also used the data set to identify the overarching clinical variables that 
directly determine gynecologic patients’ postoperative hematocrits. We were able to 
highlight 6 parameters from the larger initial set of 42 variables: patient age, BMI, 
postoperative fluid bolus orders, preoperative hematocrit, preoperative platelet count and 
intraoperative fluid loss. Few of these values are particularly unexpected. Preoperative 
hematocrit identifies the point from which a patient’s hematocrit may drop following 
surgery. A larger number of postoperative fluid bolus orders contribute to diluting the 
hematocrit. An increase in blood loss during surgery would decrease the levels of all 
blood elements, including the patient’s hematocrit value. Advanced age is well 
recognized for its ties to hypovolemia (Kenney and Chiu, 2001). Preoperative platelet 
count is an indirect indicator of overall hematocrit and representative of larger healing 
trends (Swenson et. al., 2015). With our study population’s high BMI value, the 
significant correlation between BMI and postoperative hematocrit value was not 
anticipated. The use of this variable will continue to be considered and tested with 
application of the equation to the validation data set. 
More interesting are the variables that were not found to be conclusive indicators 
of postoperative hematocrit, including operative time, the procedure route and type. Each 
of these variables makes intuitive sense in this context—a longer operative time would 
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put a patient at risk for a larger blood loss and lower hematocrit, and more extensive 
and/or invasive procedures would similarly result in a decreased patient hematocrit level. 
It is likely that the influence of these parameters, though relevant, was superseded by 
other variables. These factors will continue to be considered in subsequent validation and 
prospective testing. 
 
Comparison of Conventional Clinical and Evidence-Based Ordering 
Although the survey data gave the highest value to urine output and heart rate as 
postoperative anemia indicators, the regression equation indicated a wider range of 
variables in age, BMI, preoperative hematocrit, preoperative platelet count, estimated 
blood loss during surgery and postoperative fluid bolus orders. Sources for these points of 
disagreement may be that clinicians tend toward the most immediately measurable 
indicators of illness. Heart rate and urine output are quickly determined, as are the other 
variables mentioned in the scoring mechanism—for example, age, blood pressure and 
previous transfusions. The expediency of these measurements speaks to a desire for 
healthcare professionals to obtain the current patient information most readily available 
to them and then act quickly to manage their patients. However, it is not difficult to 
imagine how these indicators may misrepresent a patient condition. Blood pressure and 
heart rate, in particular, can be extremely variable depending upon the acute 
circumstances or a patient’s prescribed medications.  
The data-determined factors, when integrated into the electronic health record as 
planned, offer a clearer indication of the patient status and level of care required. 
Preoperative hematocrit, patient age and patient BMI all consider the patient’s starting 
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point prior to surgery. Preoperative platelet count is considered to be an indirect surrogate 
value for hematocrit. Estimated blood indicates the loss of red blood cells which 
decreases patient hematocrit. Fluid bolus orders indicate the amount of fluid that replaces 
patient intraoperative blood losses. Each of these values must be in relative balance for a 
patient’s body to heal, overcoming the stress and trauma of invasive surgery. 
 
Limitations of the Data and Predictive Models 
The scoring systems are disadvantaged because they were not developed from 
concrete data. Additionally, they were created from an extremely small professional 
subgroup, all from the same work environment, leaving little room for diversity of 
thought, experience, or discourse. With healthcare moving in an evidence-based 
direction, intuitive criteria are considered to hold limited inspiration toward improved 
healthcare quality (Munro, 2004). This reason is why this study is so important—before 
we move to entirely data-guided performance, research needs to determine if there are 
necessary aspects of clinical judgement that could be lost. 
At 338 cases, our regression data set is relatively small. As such, the coefficients 
risk bias. This difficulty is attributed to incomplete data in the charting, particularly in the 
context of intraoperative conversion from laparoscopy to laparotomy techniques. As the 
study site recently transitioned from paper charting to EHR, much of the missing data 
could not be located. Additionally, this study site is uniquely enthusiastic about the use of 
robotic techniques. Although robotic techniques are important given the lack of published 
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research including these procedures, it is not necessarily reflective of the surgery 
performed nationally where robotic equipment is entirely unaffordable in some areas. 
An issue with both models is that they do not address the frequency around which 
healthcare professionals should consider testing patients. If a practitioner examines a 
patient once following surgery, and she does not require blood work at that moment, she 
may still benefit from the data later in her recovery process. Though there is nothing in 
either model that inherently prevents regular reassessments, this issue needs to be 
continually monitored. Our intention is not to discourage clinician oversight or ownership 
of patient blood data. 
 
The Validation Set and Points of Further Study 
The next step of this study is to develop a validation subset and examine the value 
of the scoring system, or practitioner convention, compared with the evidence-based 
equation. We continue to gather data from benign hysterectomy cases that occurred in the 
date range June 1, 2016-May 31, 2017. Following a confirmation of eligibility and full 
representation of all of the necessary parameters, we will apply both the scoring system 
and the equation to the data. This will be a test of the ability of each technique to predict 
postoperative hematocrit, and the superior method may emerge. Each time we will extract 
additional benign hysterectomy data, which may serve to better tailor the score sheet and 
the equation to actual trends. We hope to gain a sense of the accuracy of each method in 
predicting postoperative hematocrit within 1%-5% of the actual result. 
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Once the most precise and effective mechanism to determine postoperative 
hematocrit has been recognized, we hope to expand the scope of application of this tool. 
In order to understand the exact parameters around which this mechanism is useful, the 
next phase of work will take into account the ineligible patient cases. To become a most 
successful option, this method must apply to the majority of surgical cases. It will be 
extremely valuable to determine the accuracy of the prediction when a female patient has 
a gynecologic surgery related to cancer, for example, or is pregnant—scenarios that both 
carry a higher transfusion risk. Figure A1 contains specific details of the milestones and 
timeline for this project.  
 The final phase of this project will require us to further utilize this tool in an even 
wider and more varied range of clinical situations. Beyond analysis with increasingly 
complicated hysterectomies, sources of data would include other general or routine 
surgeries and surgeries involving male patients. If this technique cannot be applied to 
more complicated surgical scenarios, the opportunity in the benign surgical realm alone 
makes this project critical to patient safety and quality of care. 
 
Larger Implications of Postoperative Hematocrit Prediction 
This project has two main foci: understanding the factors that lead to a 
postsurgical anemia and reducing unnecessary blood work ordered when patient 
hematocrits are within the healthy range. Essential to our postoperative hematocrit 
ordering models is a direct comparison between traditional clinical and evidence-based 
medicine. With the media and healthcare circles constantly discussing the merits of each 
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type of medical determination, we are enthusiastic about providing additional detail to 
this conversation. 
Imperative to the success of the program will be a better understanding of the 
willingness of the surgical clinician to utilize the most accurate determining strategy, 
whether it is our scoring system or the application of our equation. This may require that 
healthcare professionals be monitored for compliance, with the option for practitioner 
override as needed. Specifically, it will be important to understand how these 
professionals respond to the use of the tool in general and their reactions when prevented 
from ordering postoperative testing. We understand the ethical pressure that this change 
in procedure might place on the practitioner, particularly with the constant increase of 
malpractice insurance premiums. With ongoing validation and modification of our 
models, we want to address clinical concerns as they arise. 
Excessive postoperative testing has been evident in the healthcare landscape for 
decades without adjustment, and many practitioners are well acclimated to the process. 
With this habituation in mind, the team has devised several strategies to make the 
transition faster and increasingly comfortable. The chosen model will be an exciting 
option for preventing unnecessary laboratory work in that it requires no additional effort 
on the part of the healthcare leader as it will be directly integrated with the EMR 
software. There is no expectation that the healthcare professional will add extra work or 
steps to an assessment prior to adjusting the standard of care. With time, healthcare 
professional utilization of this tool will likely become increasingly autonomous. 
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 A primary mode of action is to educate practitioners on the value of decreasing 
the frequency of laboratory ordering. This may come in the form of an EMR alert that 
offers educational explanations detailing the reasons additional testing is not indicated, 
information about the hospital costs and the potential patient funds being spared, or even 
statistics on the course of action of other healthcare professionals in similar 
circumstances. Ideally, the software would include a mixture of all of these elements for 
practitioners, with an emphasis on the opportunities for patient benefit.  
Just as important as the willingness of the healthcare professionals to make the 
transition, administrative encouragement of the changes is essential. To address possible 
issues in adopting these procedural adjustments, we acknowledge the financial benefits 
inherent within this study. We will provide a projection of healthcare savings in the first 
3-10 years of this project. We anticipate these changes will save the healthcare setting 
progressively more as practitioners become well versed in these new parameters. 
Offering administrators a concrete sense of the savings can only add further motivation. 
We are excited about the potential ripple effects of this line of research. Medicine 
has long been criticized for its lack of evidence-based practice, and this study continues 
to further address those claims. As the data gain an increased following and influence, we 
hope to see critical evaluation of other potentially unnecessary testing areas in the 
literature. It is our belief that these types of studies will develop increased acceptance. 
Patients, healthcare practitioners and healthcare settings can only benefit from the 
limitation of such ineffective, costly and painful procedures.   
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APPENDIX 
 
Figure A1. Process Flow for Postoperative Hematocrit Study. This timeline further 
elucidates the goals and milestones associated with this study. The dates and progressions 
were determined at the start of the study, but will be modified and updated as the project 
continues to develop. 
 
May 2016
First EMR data 
pull, data clean-
up, extraction, 
analysis.
June-
December 2016
Survey of 
clinicians; 
development of 
score sheets.
Development of 
predictive 
equation.
December-
March 2017
Second EMR 
data pull; 
perform 
validation.
Determine 
superior method 
for guiding 
ordering 
behavior.
April-June 
2017
Third EMR data 
pull; expand 
surgical 
population.
Test new model 
effectiveness 
under new 
conditions. 
July 2017-July 
2018
Test model 
integration with 
EMR.
Obtain HCP
feedback.
Adjust model 
and re-test.
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